Unlike other somatic cells, human placental trophoblast cells do not express the highly polymorphic HLA-A and HLA-B human leukocyte major histocompatibility antigens that would stimulate maternal immunological rejection of the fetus. To investigate mechanisms underlying cell lineage-specific expression, cell lines were generated from homozygous matings of HLA-B27 transgenic mice. Trophoblast cell lines were generated from gestation day 10 placentas and fibroblasts were cultured from gestation day 13/14 embryos. Polymerase chain reaction (PCR) readily identified HLA-B DNA in transgenic trophoblastic cells but specific mRNA was of low abundance, being detectable by reverse transcriptase PCR but not by Northern blot hybridization. 
Introduction
Paternally-derived human leukocyte antigen (HLA) antigens expressed on fetal cells at the maternal-fetal interface would be expected to stimulate a graft rejection response in the mother that would culminate in pregnancy failure. However, rejection due to maternal recognition of foreign paternal HLA antigens has not been clearly demonstrated even though the mother and her fetus are genetically different in nearly all human pregnancies. Multiple mechanisms that include adjustments in uterine haematopoietic cell populations and expression of protective molecules in placentas are believed to protect semi-allogeneic pregnancy (Hunt, 1994; Hunt and Hutter, 1996; Runic et al., 1996; Uckan et al., 1997) .
Experiments conducted over the course of the last decade indicate that the surprising failure of mothers to reject their semiallogeneic fetuses is due, in large part, to strict regulation of HLA class I and class II gene expression in trophoblast cells comprising the fetal cellular component of the maternalfetal interface (Hunt and Orr, 1992; Schmidt and Orr, 1993; Hunt and Hutter, 1996; Hunt, 1996; Le Boutellier, 1996) . Neither the HLA class Ia genes, HLA-A and -B, nor the class II HLA-D genes, all of which are highly polymorphic, are expressed in any subpopulation of trophoblast cells (Redman et al., 1984; Hunt et al., 1987 Hunt et al., , 1989a . Trophoblast cells do not fail entirely to express class I antigens; the HLA class Ib gene, HLA-G, is strongly expressed in some trophoblast cells and a novel variant of HLA-C has also been reported (Ellis et al., 1989 (Ellis et al., , 1990 Kovats et al., 1990; Yelavarthi et al., 1991; Shorter et al., 1993) . Due to low polymorphism in HLA-G and rapid turnover by HLA-C, neither is likely to stimulate graft rejection (van der Ven and Ober, 1994; McCutcheon et al., 1995) .
The mechanism(s) underlying the repression of HLA-A, -B and the selection of other class I genes for expression in trophoblast cells remains unknown. Mice transgenic for HLA genes appear to be appropriate models for studying this problem because patterns of expression in transgenic mouse placentas are essentially the same as in human placentas (Oudejans et al., 1989; Yelavarthi et al., 1993) . In-situ hybridization and other types of experiments have shown that the trophoblast cells of HLA-B27 transgenic mice contain little if any HLA-B mRNA whereas the trophoblast cells of HLA-G transgenic mice contain abundant HLA-G mRNA (Oudejans et al., 1989; Yelavarthi et al., 1993) . In contrast, stromal cells in both transgenic strains contain mRNA from their respective transgenes.
Due to faithful reproduction across species, cell lines derived from the placentas of HLA transgenic mice can be powerful tools for investigating the mechanism(s) underlying gene selection in trophoblast cells. In the present study we developed such lines from the placentas of homozygously mated C57Bl.10 (H-2 b ) mice transgenic for HLA-B27 (Nickerson et al., 1990) using methods that have been successful in generating trophoblast cell lines from rat and mouse placentas (Hunt et al., 1989b; Rasmussen et al., 1997a,b) . In H-2 b mice, cell surface expression of the human heavy chains is high due to effective association with mouse light chains (β2m) (Nickerson et al., 1990) . Transgene expression in trophoblastic cells was then compared with expression in embryonic fibroblasts. Our studies show that the cell lines remarkably resemble their in-vivo counterparts and identify gene-specific and cell lineage-specific differences between trophoblast cells and fibroblasts.
Materials and methods
Mice, generation of placental cell lines and cloning by limiting dilution A colony of C57Bl.10 mice transgenic for the HLA-B27 gene (Nickerson et al., 1990) was established from mating pairs generously provided by C.David (Mayo Clinic, Rochester, MN, USA). The mice were housed and maintained in accordance with policies established by the University of Kansas Institutional Animal Care and Use Committee. All of the mice used to generate cell lines were positive for the HLA-B transgene when tail snips were tested by polymerase chain reaction (PCR), as described below. Breeding cages were established and pregnancy was identified by the presence of a vaginal plug, which was designated gestation day 0. Pregnant mice were killed on gestation day 10 and the placentas were dissected from the surrounding maternal and fetal tissues. Two or three placentas from a single mouse were minced and placed in 25 ml tissue culture flasks containing 5-10 ml of growth medium [Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 2ϫ10 -5 M 2-mercapto ethanol (2ME), antibiotics and 20% fetal bovine serum (FBS)] as described by Rasmussen et al. (1997a,b) . Trophoblastic cell outgrowths from the placental explants of two transgenic mice were purified from adherent fibroblasts and macrophages by transferring supernatant culture medium containing spherical clumps of nonadherent trophoblastic cells which had lifted from the plastic flasks to fresh flasks and medium. Establishment of pure cultures required five or six such transfers. The established lines, designated HLA-B1 and HLA-B3, were maintained in growth medium containing 10% FBS and were used for experiments at passages 5 to 25. The cells were cloned by limiting dilution using standard procedures (Freshney, 1987) .
Establishment of embryonic fibroblast cell lines
Standard techniques (Robertson, 1987) were used to acquire fibroblasts from gestation day 13/14 embryos. The embryos were from either homozygous matings of C57Bl.10/HLA-B27 transgenic mice or homozygous matings of C57Bl.6 mice (Harlan, Indianapolis, IN, USA). Briefly, embryos were dissected from maternal and extraembryonic tissues, finely minced and incubated twice with 5 ml 0.25% trypsin/ 0.02% EDTA solution (Sigma-Aldrich, St Louis, MO, USA) for 5 min at 37°C. After each incubation, the tissue clumps were allowed to settle, and the cells that had been released into the supernatant culture medium were collected and transferred into 5 ml of Dulbecco's modified essential medium (DMEM) containing antibiotics, nonessential amino acids (all from Sigma-Aldrich) and 10% FBS. The cells were washed by centrifugation at 500 g, resuspended in the same culture medium and placed in culture. The cells were passed into new dishes when they became confluent and were used for experiments at passages 5 to 6.
Other cell lines and IFN-γ treatments
Human endometrial adenocarcinoma cells (HeLa cells) and the RAW264.7 mouse macrophage cell line were purchased from the American Type Culture Collection (ATCC, Gaithersburg, MD, USA) and were maintained as recommended by the ATCC. The SM-9 and SM-10 cell lines derived from Swiss-Webster mouse placentas were maintained as described above for the HLA-B1 and HLA-B3 cell lines. IFN-γ treatments consisted of adding 100 IU/ml of recombinant mouse IFN-γ (rmIFN-γ, provided by the American Cancer Society through Shering-Plough) to mouse cells or recombinant human IFN-γ (rhIFN-γ; Genzyme, Cambridge, MA, USA) to human cells growing in tissue culture flasks or in 96-well flat-bottom microplates and continuing the cultures for 48 h.
Immunocytochemistry
Expression of intermediate filaments was tested by immunocytochemistry using previously described procedures (Hunt et al., 1997) . In brief, HLA-B1 and HLA-B3 cells were seeded onto Lab-Tek Tissue Culture Chamber Slides (Nalge Nunc International, Naperville, IL, USA) and cultured at 37°C, 5% CO 2 until nearly confluent. The cell monolayers were rinsed with phosphate-buffered saline (PBS), dried and fixed in acetone, then stained with monoclonal antibodies to pan-cytokeratin or vimentin (Biogenex, San Ramon, CA, USA, at dilutions of 1:100 and 1:750 respectively). To identify non-specific binding of the secondary reagent, mouse immunoglobulin G (IgG) at the same concentration was substituted for the primary antibodies. Binding was detected using an avidin-biotin immunoperoxidase staining kit from Zymed (South San Francisco, CA, USA).
Identification of alkaline phosphatase expression
Alkaline phosphatase was evaluated by measuring the conversion of the substrate, p-nitrophenyl phosphate (pNPP), by cells in microwells as previously described by Hunt et al. (1989b) . Briefly, cells were harvested by trypsinization, seeded into 96-well flat bottom microplates (5ϫ10 4 cells/well in 0.2 ml growth medium containing 10% FBS) and cultured for 48 h. The supernatant culture medium was carefully aspirated from each well and the cells were incubated for 15-120 min with 0.2 ml of substrate (2 mg/ml pNPP, Sigma 104; Sigma-Aldrich) in buffer containing 100 mM Tris-HCl, pH 9.5, 100 mM NaCl, and 5mM MgCl 2 ). The reaction was terminated by adding 0.05 ml 2 M NaOH. Substrate conversion was read using an Elx808 microplate reader (Bio-Tek Instruments, Winooski, VT, USA) at a wavelength of 405 nm.
Flow cytometry
Flow cytometry was performed as described previously (Yang et al., 1995) using antibodies specific for mouse macrophages (F4/80, Austyn and Gordon, 1981) , mouse H-2 class II (Ia) antigen (M5/114, Boehringer Mannheim Biochemicals, Indianapolis, IN, USA) and HLA-B/C (4E, Yang et al., 1984) . Binding was detected using a fluoresceinated anti-mouse IgG from Vector Laboratories (Burlingame, CA, USA). Mouse IgG (Sigma Aldrich) at the same concentration as the primary antibodies was used to control for nonspecific binding.
Polymerase chain reaction (PCR)
The HLA-B27 transgene was identified in cell line and tail snip DNA by PCR. Briefly, cell lines were cultured in growth medium containing 10% FBS. When~80% confluency was reached, the cell layers were washed with PBS (pH, 7.4) and digested with DNA lysis buffer (50 mM Tris-Cl, 1 mM EDTA, 100 mM NaCl, 1% SDS, pH 8.0) containing 10 mg/ml proteinase K overnight at 55°C. Subsequently, the samples were treated with RNase (10 mg/ml) for 30 min at 37°C. DNA was extracted once each with buffer-saturated phenol, phenol/ chloroform-isoamyl alcohol (24:1) and chloroform-isoamyl alcohol followed by ethanol precipitation and resolubilization in water. To extract tail DNA, tail snips were minced in DNA lysis buffer and incubated at 55°C overnight. The lysate was treated with RNase and then DNA was extracted with phenol/chloroform-isoamyl alcohol followed by ethanol precipitation. PCR was carried out according to the manufacturer's instructions (Perkin Elmer, Norwalk, CT, USA) with modifications. Genomic DNA samples were added in 50 µl of 1ϫ PCR reaction buffer containing 200 µM of each dNTP, 1 mM MgCl 2 , 1 µM of each primer and 2.5 units of Taq polymerase. The samples were subjected to 30 cycles in a programmable thermocycler with the following cycle parameters: denaturation at 94°C for 1 min, 62°C for 2 min, 72°C for 2 min and extension at 72°C for 7 min. The PCR products were separated on 3% Seakem, Nusieve (3:1) agarose gels containing 0.05 µg/ml ethidium bromide and were visualized by UV transillumination. The primers for HLA-B27 (forward primer, 5Ј-CTGTGCCTTGGCCTTGCAGA-3Ј; reverse primer, 5ЈCCACTCCATGAGGTATTTCCA-3Ј) were obtained from Integrated DNA Technologies, (Coralville, IA, USA) and the primers for G3PDH (forward primer, 5Ј-TGAAGGTCGGTGTGAACGGATTT-GGC-3; reverse primer, 5Ј-CATGTAGGCCATGAGGTCCACCAC-3Ј) were obtained from Clontech (Palo Alto, CA, USA).
Reverse transcriptase-PCR (RT-PCR)
Messenger RNA was extracted from untreated and IFN-γ-treated HLA-B1 and HLA-B3 cells using Fast Track 2.0 mRNA isolation kits (Invitrogen, San Diego, CA, USA), and was reverse transcribed into first-strand cDNA using Moloney murine leukaemia virus (MuLv) and the oligo (dT) 16 priming method as described before (Hunt et al., 1997) . The reverse transcription was performed using the following cycle parameters: 10 min at 25°C (extension of oligo dT 16 ), 60 min at 42°C (reverse transcription), 5 min at 99°C (denaturation) and 5 min at 5°C. The samples were then subjected to PCR as described above. Northern blot hybridization procedures A 360 bp cDNA sequence specific for HLA-B was cleaved from the plasmid pSP6 (Promega Biotech, Madison, WI, USA) by digestion with PstI and EcoRI restriction endonucleases as described before (Hunt et al., 1988) . [ 32 P]-radiolabelled probe was synthesized from the isolated fragment using the random primer DNA labelling method as recommended by the manufacturer (Gibco BRL, Grand Island, NY, USA). A 1.2 kb DNA segment of the human G3PDH gene was isolated and radiolabelled using the same method. Total cell RNA was isolated from untreated and IFN-γ-treated HLA-B1 and HLA-B cells and from SM-10 cells (negative control) as well as HeLa cells (positive control) using a TRIzol RNA isolation kit (Gibco). RNA samples were separated on 2.2 M formaldehyde, 1% agarose gels, and were transferred to nylon membranes in 20ϫ sodium chloride/ sodium citrate (SSC). RNA was cross-linked to the membranes by UV irradiation and hybridized with one or the other of the two [ 32 P]-labelled probes in Quik-hyb hybridization solution (Stratagene, La Jolla, CA, USA) as recommended. The blots were subjected to autoradiography. Blots hybridized with the HLA-B probe were subsequently stripped and re-hybridized with the G3PDH probe and again subjected to autoradiography.
Cell enzyme-linked immunosorbent assay (ELISA)
Class I antigens were measured by using a cell ELISA as previously described (Hunt et al., 1990; Roby et al., 1994) . Cells in 96-well flat bottom microplates were fixed with freshly prepared 0.05% glutaraldehyde in PBS and the fixation was quenched with 0.2 M glycine. Non-specific binding sites were blocked by treatment with 5% Carnation Milk in PBS for 1 h at room temperature. After washing with Tris-buffered saline (0.05 M Tris-HCl plus 0.15 M NaCl) 819 containing 0.05% Tween-20 (wash solution, 200 µl/well), the cells were incubated for 30 min at 37°C with 50 µl of mouse monoclonal antibody. The monoclonal antibody W6/32 (1:4000 dilution of partially purified ascites; ATCC) was used to detect human HLA class I antigens and CTDb (0.5 µg/ml; Caltag Laboratories, South San Francisco, CA, USA) was used to detect mouse H-2D b class I antigens. Normal mouse IgG (Vector Laboratories) at the same concentration as the primary antibodies was used as a control. The plates were again washed three times and incubated for 30 min at 37°C with peroxidase-labelled horse anti-mouse IgG (Vector Laboratories). Bound antibody was detected by adding freshly prepared TMB peroxidase substrate (Kirkegaard and Perry, Gaithersburg, MD, USA; 100 µl/well) and incubating the plates at reverse transcription for 15 min. The reaction was stopped by the addition of 50 µl/ well of 1 M H 3 PO 4 , then the plates were read at 450 nm.
MTT assays
In conjunction with ELISA assays, duplicate plates were prepared and changes in cell number during the course of experimental treatments were evaluated using a 3-[4,5-Dimethylthiazol-2-yL]2,5-diphenyl tetrazolium bromide; thiazolyl blue (MTT)-based cell proliferation assay kit (CellTiter 96™; Promega) according to the manufacturer's instructions.
Statistical analysis
Analyses were performed using the Graph Pad InStat statistics program (Graph Pad Software Inc., San Diego, CA, USA).
Results

Generation and characterization of HLA-B27 transgenic trophoblastic cell lines
Two trophoblastic cell lines were generated from gestation day 10 placentas of homozygously mated C57Bl.10/HLA-B27 transgenic mice using the in-vitro explant culture methods and enrichment procedures that have been successful in establishing trophoblastic cell lines from rat and outbred Swiss-Webster mouse placentas (Hunt et al., 1989b; Rasmussen et al., 1997a,b) . Previously generated lines from Swiss-Webster mice (SM9-1, SM10) lines were used as controls in the experiments reported here. Five to six transfers of transgenic and nontransgenic trophoblastic cells, which form spherical aggregates that lift from the tissue culture flasks, were required to eliminate fibroblasts and other adherent cellular contaminants. Passages 5 or 6 to 25 were then used for the experiments.
Cell lines developed in this manner had similar morphological features. Figure 1 shows that the trophoblastic cells obtained from Swiss-Webster mouse placentas, the SM9-1 cell line ( Figure 1A) , as well as those generated from HLA-B27 transgenic placentas, the HLA-B1 line ( Figure 1B ), ranged in shape from round to fibroblastic. Variability in cell size was also a feature. However, cloning by limiting dilution revealed that all of the morphological variants could be generated from a single cell. Figure 2 shows that cells in the HLA-B1 line were uniformly positive with anti-cytokeratin ( Figure 2A ) and negative with anti-vimentin ( Figure 2B ). The staining of nuclei in Figure 2B resulted from the use of haematoxylin as a counterstain, which stains nucleic acids. These experiments showed that the cells were of epitheloid origin, as expected for trophoblastic cells, and contained few if any stromal cell contaminants, which would express vimentin intermediate filaments. To evaluate this further, the HLA-B1 line was tested for cells expressing the F4/80 macrophage antigen and H-2 class II antigens using flow cytometry. Although RAW264.7 cells used as positive controls were strongly positive for both antigens, no positive cells were identified in the cell lines (data not shown). Figure 3 shows that the HLA-B1 and HLA-B3 lines expressed alkaline phosphatase, a marker for rodent labyrinthine trophoblast cells (Hunt et al., 1989b) , in a time-dependent manner. The substrate conversion values were similiar to those obtained with Jar human choriocarcinoma cells.
Detection of the HLA-B27 transgene in trophoblastic cell lines
In order to determine whether the trophoblastic cells carried the HLA-B27 transgene, DNA samples from the HLA-B1 and HLA-B3 trophoblastic cell lines were tested by PCR. The results are illustrated in Figure 4 . Both lines contained HLA-B27 DNA, as shown by the presence of a 210 bp amplicon. The same sized amplicon was generated from tail DNA taken from HLA-B27 transgenic mice. Thus, the transgene was stably maintained in the trophoblastic cell lines. DNA from the nontransgenic SM-10 trophoblastic cell line did not contain HLA-B27 mRNA (not shown).
Trophoblastic cell lines contain low abundance HLA-B27 mRNA
Total cell RNA was evaluated for HLA-B mRNA by using Northern blot hybridization procedures. As shown in Figure  5 , neither of the two cell lines derived from HLA-B27 placentas contained detectable HLA-B27 mRNA even though hybridization signals with the [ 32 P]-labelled G3PDH probe indicated that intact mRNA was present. HLA-B-specific message was not induced by treating the HLA-B transgenic trophoblastic cells with rmIFN-γ for 6 h, and incubation of the blots for extended time periods did not reveal any hybridization signals. In contrast, the human endothelial adenocarcinoma cell line, HeLa, used as a positive control contained high levels of both HLA-B and G3PDH mRNA and, as expected, the non-transgenic trophoblastic cell line, SM-10, used as a negative control contained G3PDH but not HLA-B mRNA. Equal loading of the lanes is illustrated by the approximately equal intensities of the 18S and 28S bands on the matching ethidium bromide-stained agarose gel. The HeLa cells routinely contained more G3PDH mRNA than the trophoblastic cells, which were similar to one another.
In order to identify low abundance message, poly (A) ϩ RNA extracted from the trophoblastic cell lines was tested by RT-PCR. Examination of ethidium bromide stained gels documented that the preparations used in these experiments were not contaminated with DNA. HLA-B27 mRNA was detectable and the amplicons from HLA-B1 and HLA-B3 cells exposed to 100 IU/ml of rmIFN-γ appeared to be of higher intensity (Figure 6 ). Although the same samples were subjected to RT-PCR using primers that amplified G3PDH mRNA and the signals obtained for untreated and IFN-γ-treated cells were of approximately equal intensity, no more precise quantitative measures were applied. Thus, no conclusions were drawn regarding the IFN-γ-inducibility of the transgene. Tail snip DNA from an HLA-B27 transgenic mouse served as a positive control and mRNA from the non-transgenic cell line, SM9-1, served as a negative control. HLA-B mRNA and DNA yielded the same size of amplicon because the primers spanned a single exon.
We concluded from these experiments that expression of the HLA-B transgene was repressed in trophoblastic cells by either transcriptional or immediate post-transcriptional events.
Trophoblastic cell lines do not contain HLA-B27 protein
As low levels of HLA-B mRNA were detectable in the trophoblastic cell lines, we tested for translation into HLA-B protein. Table I shows the results of cell ELISA experiments. The monoclonal antibody, W6/32, which identifies all class I heavy chains in association with β2m, failed to identify any human class I protein in either of the mouse trophoblastic cell lines. Recombinant mIFN-γ did not induce expression; as illustrated in Figure 7 , the cells remained refractory even when exposed to high doses of rmIFN-γ. Further flow cytometry experiments that used the monoclonal antibody 4E, which detects HLA-B/C, also did not reveal any HLA-B protein in the HLA-B1 line (data not shown). In the studies presented in Table I , W6/32 binding protein was undetectable on the negative control trophoblast cell line from Swiss-Webster mice, the SM-10 line. In contrast, human HeLa cells used as a positive control constitutively expressed HLA class I antigens and, as expected, higher levels were induced by rhIFN-γ.
As IFN-γ affects growth of some cells, which could confound interpretation of microplate cell ELISA assays, duplicate plates were established and tested for cell numbers using the MTT assay. All of the lines were slightly growth inhibited by species-specific rIFN-γ (Table I ) but these minor changes in the number of cells in the wells seemed unlikely to account for the negative results obtained in these assays.
Thus, these studies indicated that although the trophoblastic cell lines carried the HLA-B27 transgene and contained low levels of specific mRNA, the antigen was neither constitutively expressed nor inducible with IFN-γ.
Transgenic trophoblastic cells express endogenous, IFN-γ-inducible H-2D b antigens
In order to determine whether the failure of untreated and IFN-γ-treated HLA-B1 and HLA-B3 cells to express HLA-B antigens might be due to an overall inability to produce class I antigens, cell ELISA experiments were performed using an antibody to H-2D b (Table I) . In contrast to the negative results obtained on the trophoblastic lines with the anti-human class I monoclonal antibody, W6/32, H-2D b antigens were detected on both lines by this method. Binding of anti-H-2D b to the 822 HLA-B1 cells was lower than binding to the HLA-B3 cells but exposure to IFN-γ induced statistically significant enhancement of antigen expression in both lines. The mouse trophoblastic SM-10 line, which does not bear H-2D b antigens, yielded negative results as did the HeLa human endometrial adenocarcinoma cell line.
Therefore, lack of expression of the HLA-B27 antigen by the trophoblastic cell lines was not due either to an inability to display major histocompatability complex (MHC) class I antigens, or to an inability to respond to IFN-γ.
HLA-B27 transgenic fibroblasts express IFN-γ-inducible HLA-B27 and H-2D b
In order to draw comparisons between trophoblastic cells and other somatic cells, we established fibroblast cell cultures from HLA-B27 transgenic and non-transgenic embryos. As illustrated in Figure 8 , PCR analysis identified the HLA-B27 transgene in DNA from the transgenic but not the nontransgenic fibroblasts. Table I and Figure 7 show that fibroblasts established from HLA-B27 transgenic embryos expressed little if any HLA-B protein but that expression was induced with IFN-γ in a concentration-dependent manner. Non-transgenic fibroblasts did not bind W6/32. Table I also shows that both transgenic and non-transgenic fibroblasts bound the monoclonal antibody to H-2D b and that binding was dramatically increased by treatment with IFN-γ. As expected, the human HeLa cells did not bind anti-H-2D b . The MTT assay demonstrated that as with the trophoblastic cells, growth of the fibroblasts was not dramatically altered by the IFN-γ. These experiments were repeated twice with essentially the same results. Therefore, increased cell numbers did not account for the increased binding of antibody observed in cell ELISAs.
Collectively, this group of experiments demonstrated that in striking contrast to trophoblastic cells, transgenic fibroblasts express IFN-γ-inducible HLA-B antigens as well as H-2D b antigens.
Discussion
This study reports several major findings: (i) stable trophoblastlike cell lines can be generated from transgenic mice using the technology developed for generation of lines from rat and non-transgenic mouse placentas; (ii) expression of a human transgene in the lines faithfully reflects expression of the same transgene in transgenic mouse placentas in vivo; (iii) transcription and translation of the HLA class Ia gene, HLA-B27, is uniquely suppressed in mouse trophoblast cells just as it is in human trophoblast cells; (iv) regulation is achieved at the level of transcription or immediate post-transcription.
The transgenic mouse trophoblastic cell lines are similar to the rat and mouse lines developed previously (Hunt et al., 1989b; Rasmussen et al., 1997a,b) in that they express cytokeratin but not vimentin intermediate filaments, contain alkaline phosphatase enzyme activity, have low constitutive expression of H-2 class I antigens that are IFN-γ-inducible and are negative for H-2 class II antigens. The in-vivo counterparts for these lines remain uncertain but their characteristics suggest Gillaudeux et al., 1995) . Trophoblast cells harvested from normal human placentas can be used for many important experiments (Bajoria et al., 1997; Goto et al., 1997) but are short-lived, do not proliferate, contain some stromal cells that could confound interpretation of experimental results on HLA class I and tend to form multinucleated giant cells in culture (Kliman et al., 1986) . In contrast, the new mouse placental cell lines, which were not deliberately transformed, grow readily and remain phenotypically stable from passages 5 to 25. In-vitro culture conditions might alter their characteristics thereafter as has been reported for the rat lines (Kunz et al., 1996) . The trophoblastic cell lines faithfully mimicked transgene expression by their counterparts in transgenic mouse placentas. In the lines, Northern blot hybridization experiments failed to detect HLA-B27 mRNA (this study) and in the transgenic mice, in-situ hybridization studies failed to detect HLA-B27 mRNA in trophoblast cells (Oujedans et al., 1989) . Consistent with the low abundance of HLA-B transcripts, both cell ELISA and flow cytometry failed to identify HLA-B protein in/on the trophoblast-like cells even after exposure to IFN-γ. IFN-γ-induction experiments have not been done to test the inducibility of the transgene in the placentas of transgenic mice, but our results on the lines would suggest that negative results would be obtained in the trophoblast lineage.
In the transgenic trophoblastic cells, expression of HLA-B27 was restricted at the level of transcription or immediate post-transcription by IFN-γ-insensitive mechanisms. Explanations for this unusual phenomenon include: (i) the presence of cis-or trans-acting transcriptional repressor elements; and (ii) rapid degradation of HLA-B27 mRNA. One cis-acting mechanism, CpG island methylation, seems not to explain the lack of class Ia expression in normal human syncytiotrophoblast (Guillaudeux et al., 1995) but trans-acting nuclear binding factors factors such as the one identified by Wakimoto et al. (1995) remain possibilities. A negative regulatory element has been located in a murine H-2 class I negative embryonal carcinoma cell line that is 180 bp upstream from the transcription start site. In agreement with the idea of unique negative regulation of MHC antigens in this cell type, Murphy et al. (1997) have recently reported that trophoblast cells in several species restrict class II expression by this mechanism. The study included cell lines we had generated from the placentas of gestation day 9/10 Swiss-Webster mice which served as controls in the present experiments.
Although expression of the human class Ia HLA-B transgene was restricted in mouse trophoblast cells just as it is in human trophoblast cells, the mouse cells expressed endogenous H-2D b class Ia antigens, and these antigens were IFN-γ-inducible. Observations on the H-2D b antigens in the lines were therefore in accord with expression patterns in vivo; some subpopulations of mouse trophoblastic cells contain paternally-derived class I antigens after gestation day 12 and these can be up-regulated by administering IFN-γ to pregnant mice (Mattsson et al., 1991 (Mattsson et al., , 1992 . The ability of the HLA-B3 line to express IFN-γ-inducible H-2D b indicated that the cells did not lack IFN-γ receptors, which appear between gestation days 10 and 12 (Chen et al., 1994) , and also did not lack either the transporters for antigen processing (Tap-1, -2) or β2m. Restricted expression of class I antigens by certain subpopulations of trophoblast cells in vivo is associated with the absence of Tap-1 and β2m transcripts (Jaffe et al., 1991; Roby et al., 1996) . However, low IFN-γ receptors, Tap or β2m might account for the unexplained low levels of H-2D b expression in the HLA-B1 line, an observation that was not pursued further in this study.
It is not certain how protection from graft-rejecting maternal cells is provided to mouse trophoblast cells expressing paternal class Ia antigens, but the antigens may not be delivered to the 824 trophoblast cell surface (Misra et al., 1993) and/or the absence of class II antigens on trophoblast may be of over-riding importance (Gustafsson et al., 1997) .
Trophoblast cell restriction of HLA-B27 expression was unique; cells derived from the inner cell mass, i.e. embryonic fibroblasts, strongly expressed the antigens following treatment with IFN-γ. These results are consistent with studies showing that: (i) the HLA-B27 transgene is expressed in inner cell mass-derived placental cells in vivo (Oujedans et al., 1990) ; and (ii) an HLA-B7 transgene is expressed in transgenic mouse embryos in a developmentally predictable pattern that resembles H-2 class I (Kushida et al., 1997) . The HLA-B27 transgenic embryonic fibroblasts, which also express IFN-γ-inducible H-2D antigens, will therefore be valuable controls for further studies on trophoblast-specific restriction elements.
In summary, the results of this study strongly suggest that the restrictions preventing HLA-B expression in human trophoblast cells also operate in transgenic mouse trophoblast cells, and that these are cell-lineage dependent and IFN-γ-insensitive. A particularly striking similiarity is seen between the expression profile in mouse trophoblastic cells and human villous trophoblast cells. The latter cells often contain HLA class I mRNA but do not exhibit class I protein that is detectable with the monoclonal antibody W6/32, and do not produce immunoreactive class I protein upon stimulation with IFN-γ (Hunt et al., 1987) . Thus, the cell lines reported here may be extremely useful model systems for further investigations of the mechanisms underlying non-expression of polymorphic HLA class Ia genes in trophoblastic cells.
